Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Gastrointestinal 1

Conditions

Prostatic Neoplasms 121Neoplasm Metastasis 12Prostate Cancer Metastatic 4Oligometastatic Prostate Cancer 3Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 3Metastatic Hormone-sensitive Prostate Cancer 3Adenocarcinoma 3Radiation Injuries 2Prostatic Diseases 2Prostate CA 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neoplasms 2Metastatic Castration-resistant Prostate Cancer 2Urologic Diseases 1Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Stage IV Prostate Adenocarcinoma AJCC v7 1Stage I Prostate Adenocarcinoma 1Salivary Gland Neoplasms 1Recurrence 1Prostatic Neoplasms, Castration-Resistant 1Prostate Adenocarcinoma 1PSA Level Greater Than 0.03 1Oligorecurrent and Oligoprogressive Prostate Cancer Patients 1Non-metastatic, Hormone naïve Prostate Cancer 1Neoplasm Recurrence, Local 1Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) 1Metastatic Hormone-Sensitive Prostate Cance 1Metastatic Hormone Sensitive Prostate Cancer 1Metastatic Castration-sensitive Prostate Cancer 1

Interventions

Radiotherapy 38Radiotherapy, Intensity-Modulated 12Cisplatin 12Amifostine 11Paclitaxel 7Carboplatin 7Radiosurgery 6Etoposide 5Brachytherapy 5Surgical Procedures, Operative 4Low-Level Light Therapy 4Donepezil 4Chemotherapy, Adjuvant 4Bevacizumab 4sargramostim 3Surveys and Questionnaires 3Radiation 3Proton Therapy 3Neuropsychological Tests 3Mental Status and Dementia Tests 3Magnetic Resonance Spectroscopy 3Heavy Ion Radiotherapy 3Filgrastim 3Diet Therapy 3Chemoradiotherapy 3Blood Specimen Collection 3Radiotherapy, Conformal 2Radiation Dose Hypofractionation 2Patient Reported Outcome Measures 2Lithium 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Radiation Injuries × Androgen Antagonists × Clear all
NCT07483658 2026-03-19

HYP-OP-RT

CHU de Quebec-Universite Laval

Phase NA Not yet recruiting
434 enrolled
GastrointestinalGenitourinary

Gastrointestinal Diseases, Neoplasm Recurrence, Local, Prostatic Neoplasms, Radiation Injuries, Urologic Diseases

NCT05003752 2023-03-07

Hypo-Combi

German Oncology Center, Cyprus

Phase 1/2 Active not recruiting
40 enrolled
Genitourinary

Prostatic Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡